GSK3B and type 2 diabetes mellitus: Our previous multicenter case-control study showed that aging, up-regulation of platelet glycogen synthase kinase-3β (GSK-3β), impaired olfactory function, and ApoE ε4 genotype were associated with cognitive decline in type 2 diabetes mellitus (T2DM) patients.